This Stock Just Doubled in 1 Day -- Is It Still a Buy?
Unsurprisingly, Akero owes this incredible one-day gain to data from a midstage clinical trial. Akero Therapeutics is ...
Akero Therapeutics Inc. (AKRO): Among The Stocks That Started The Year On A High
We recently compiled a list of the 5 Stocks That Started The Year On A High. In this article, we are going to take a look at ...
Leerink raises 89bio stock target to $37 on NASH study optimism
Leerink Partners analyst Thomas Smith adjusted the price target for 89bio Inc . (NASDAQ:ETNB) to $37 from $34, while ...
Why Akero Therapeutics (AKRO) Is Among the Best Booming Stocks to Invest in Now?
We recently compiled a list of the 12 Best Booming Stocks to Invest in Now. In this article, we are going to take a look at ...
GEN20h
StockWatch: Whirlwind Week for Nvidia as Investors Weigh DeepSeek’s Impact
What especially shook investors was the prospect that China may have closed the tech gap with the United States in AI and especially DeepSeek’s claim that it developed R1 for just $5.6 million—a far ...